Quick-Med Technologies, Inc.
Other OTCTotal Valuation
Quick-Med Technologies, Inc. carries a market capitalization of 29,877.00, placing it among publicly traded companies globally. Its enterprise value stands at 2.48M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 29,877.00 |
| Enterprise Value | 2.48M |
Share Statistics
Quick-Med Technologies, Inc. currently has 37.35M shares outstanding.
| Shares Outstanding | 37.35M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 2.45, and the price-to-book ratio stands at -0.08.
| PE Ratio | N/A |
| PS Ratio | 2.45 |
| PB Ratio | -0.08 |
| P/TBV Ratio | -0.24 |
| P/FCF Ratio | 17.98 |
| P/OCF Ratio | 36.19 |
Enterprise Valuation
| EV / Sales | 2.67 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 4.33 |
Financial Position
Quick-Med Technologies, Inc. maintains a current ratio of 0.03, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -2.81, indicating conservative leverage, while an interest coverage ratio of -0.76 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.03 |
| Quick Ratio | 0.03 |
| Debt / Equity | -2.81 |
| Debt / EBITDA | -0.75 |
| Interest Coverage | -0.76 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -106.82 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -3.06 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Quick-Med Technologies, Inc.'s stock has gained approximately 700.00002% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | 700.00002% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Quick-Med Technologies, Inc. generated 928,492.00 in revenue and converted that into -713,073.00 in net income, yielding earnings per share of -0.02. EBITDA reached -339,052.00, while operating income came in at -376,076.00.
| Revenue | 928,492.00 |
| Gross Profit | 648,240.00 |
| Operating Income | -376,076.00 |
| Pretax Income | -713,073.00 |
| Net Income | -713,073.00 |
| EBITDA | -339,052.00 |
| EBIT | -376,076.00 |
| Earnings Per Share (EPS) | -0.02 |
Balance Sheet
Quick-Med Technologies, Inc. holds 49,677.00 in cash and equivalents against 254,891.00 in total debt, resulting in a net debt position of 205,214.00. Total book value stands at -28.36M, with working capital of -8.30M providing operational flexibility.
| Cash & Cash Equivalents | 49,677.00 |
| Total Debt | 254,891.00 |
| Net Debt | 205,214.00 |
| Equity (Book Value) | -28.36M |
| Book Value Per Share | -0.76 |
| Working Capital | -8.30M |
Cash Flow
Quick-Med Technologies, Inc. produced 62,948.00 in operating cash flow over the past twelve months. After subtracting -63,772.00 in capital expenditures, free cash flow totaled -824.00 - equivalent to 0.00 per share.
| Operating Cash Flow | 62,948.00 |
| Capital Expenditures | -63,772.00 |
| Free Cash Flow | -824.00 |
| FCF Per Share | 0.00 |
Margins
Quick-Med Technologies, Inc. operates with a gross margin of 69.82, reflecting its pricing power and cost economics. The operating margin of -40.50 and net profit margin of -76.80 provide insight into operational efficiency.
| Gross Margin | 69.82 |
| Operating Margin | -40.50 |
| Pretax Margin | -76.80 |
| Profit Margin | -76.80 |
| EBITDA Margin | -36.52 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 1.32 |
| FCF Yield | 5.56 |
Scores
Quick-Med Technologies, Inc. posts an Altman Z-Score of -146.67, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -146.67 |